Acute Myeloid Leukemia News and Research

RSS
Acute Myeloid Leukemia (AML) is a rapidly progressing cancer of the blood characterized by the uncontrolled proliferation of immature blast cells in the bone marrow. The Leukemia and Lymphoma Society estimates that over 13,000 new cases of AML were diagnosed and approximately 9,000 deaths from AML occurred in the U.S. during 2007. AML is generally a disease of older adults, and the median age of a patient diagnosed with AML is about 67 years. A majority of elderly patients are not considered candidates for standard induction therapy or decline therapy, resulting in an acute need for new treatment options.
Modified blood thinner may be first promising method to prevent repercussions after TBI

Modified blood thinner may be first promising method to prevent repercussions after TBI

FDA approves drug to treat patients with newly diagnosed CD33-positive AML

FDA approves drug to treat patients with newly diagnosed CD33-positive AML

Pfizer receives FDA approval for new therapy to treat adults and children with AML

Pfizer receives FDA approval for new therapy to treat adults and children with AML

Spot Leukaemia campaign launched to reduce delays in diagnosis

Spot Leukaemia campaign launched to reduce delays in diagnosis

New research program receives DKK 100 million in funding from Novo Nordisk Foundation

New research program receives DKK 100 million in funding from Novo Nordisk Foundation

FDA approves fixed dose combination chemotherapy for subtypes of AML that have poor survival outcomes

FDA approves fixed dose combination chemotherapy for subtypes of AML that have poor survival outcomes

New drug Idhifa for patients with refractory acute myeloid leukemia (AML) gets FDA nod

New drug Idhifa for patients with refractory acute myeloid leukemia (AML) gets FDA nod

ERYTECH partners with Queen’s University to advance its product candidate for treating arginase-1 deficiency

ERYTECH partners with Queen’s University to advance its product candidate for treating arginase-1 deficiency

Prolonged use of cancer inhibitors can lead to severe cardiovascular problems

Prolonged use of cancer inhibitors can lead to severe cardiovascular problems

Researchers trace origins of AML relapse to rare therapy-resistant stem cells

Researchers trace origins of AML relapse to rare therapy-resistant stem cells

PNNL-OHSU scientists part of NCI effort to study about role of proteins in cancer biology

PNNL-OHSU scientists part of NCI effort to study about role of proteins in cancer biology

Researchers discover how mutations in protein network drive high-risk leukemias

Researchers discover how mutations in protein network drive high-risk leukemias

Study finds steady decline in severe health problems for childhood cancer survivors

Study finds steady decline in severe health problems for childhood cancer survivors

Investigational compound inhibits cancer-specific mutations in mice

Investigational compound inhibits cancer-specific mutations in mice

Study shows how different genetic mutations cause acute myeloid leukemia

Study shows how different genetic mutations cause acute myeloid leukemia

Researchers show how DPF2 protein controls blood cell production in leukemia

Researchers show how DPF2 protein controls blood cell production in leukemia

Researchers identify new drug target for two common types of myeloid leukemia

Researchers identify new drug target for two common types of myeloid leukemia

UT Health scientists discover epigenetic changes that contribute to AML

UT Health scientists discover epigenetic changes that contribute to AML

FDA approves new AML drug after clinical testing at Dana-Farber

FDA approves new AML drug after clinical testing at Dana-Farber

Study suggests how existing and emerging immunotherapy treatments could be successful for sarcomas

Study suggests how existing and emerging immunotherapy treatments could be successful for sarcomas